CD66a (CEACAM1) is the only CD66 variant expressed on the surface of plasma cells in multiple myeloma: a refined target for radiotherapy trials?

Br J Haematol. 2010 Jun;149(5):795-6. doi: 10.1111/j.1365-2141.2010.08100.x. Epub 2010 Mar 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antigens, CD / metabolism*
  • Antigens, Neoplasm / metabolism*
  • Cell Adhesion Molecules / metabolism*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma / immunology*
  • Plasma Cells / immunology*
  • Radioimmunotherapy / methods

Substances

  • Antigens, CD
  • Antigens, Neoplasm
  • CD66 antigens
  • Cell Adhesion Molecules